STOCK TITAN

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Zymergen Inc. announced it will report preliminary financial results for Q1 2022 on May 12, 2022, after market close. The management will host a conference call at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss these results. Investors can access the webcast via the company’s investor relations page. Zymergen specializes in designing and producing innovative molecules, microbes, and materials for various markets, emphasizing sustainable practices and partnerships with nature.

Positive
  • Scheduled preliminary financial results announcement for Q1 2022, indicating transparency and communication with investors.
Negative
  • None.

EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after market close on Thursday, May 12, 2022. The company’s management will host a conference call beginning at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss its results.

A webcast of the conference call can be accessed at https://investors.zymergen.com/.

About Zymergen

Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets. We partner with nature to make better products, a better way, for a better world.

Investor Contact
investors@zymergen.com


FAQ

When will Zymergen announce its Q1 2022 financial results?

Zymergen will announce its Q1 2022 financial results on May 12, 2022, after market close.

What time is Zymergen's conference call regarding Q1 2022 results?

The conference call will take place at 1:30 PM Pacific Time / 4:30 PM Eastern Time.

How can I access the Zymergen Q1 2022 results conference call?

The conference call can be accessed via the webcast on Zymergen's investor relations page.

What industry is Zymergen involved in?

Zymergen operates in the biotech industry, focusing on molecules, microbes, and materials.

ZY

NASDAQ:ZY

ZY Rankings

ZY Latest News

ZY Stock Data

253.58M
96.93M
6.27%
65.09%
3.6%
Specialty Chemicals
Basic Materials
Link
United States
EmeryVille